Poseida Therapeutics, Inc. (PSTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

2.6400

-0.0300

(-1.12%)

At close: 04:00PM EST

2.6600

+0.02

(+0.76%)

After hours:

04:16PM EST

Loading interactive chart…

PR Newswire
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2023
Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced updates and financial results for the third quarter ended September 30, 2023.
PR Newswire
Poseida Therapeutics to Present at Two Upcoming Investor Conferences
Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced that the Company will participate in the following upcoming investor conferences in November:
Zacks
Poseida Therapeutics, Inc. (PSTX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Poseida Therapeutics, Inc. (PSTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.